Cibus, Inc. Class A Common Stock
CBUSCibus, Inc. Class A (CBUS) is a biotechnology company focused on developing innovative gene-editing technologies for agriculture. They aim to create healthier, more sustainable crops through precise and efficient genetic modifications, helping to address global food security and environmental challenges.
Company News
Cibus, Inc. (Nasdaq: CBUS) announced the appointment of Craig Wichner, founder of Farmland LP, as Chief Executive Officer, with Peter Beetham transitioning to President and Chief Operating Officer. The leadership change is part of the company's succession planning strategy as it focuses on commercializing its gene-editing technology for plant tra...
Cibus, Inc. has successfully transferred gene-edited herbicide tolerance traits in rice to its partner Interoc, marking a strategic milestone toward commercializing enhanced seed products in the Latin American market. The achievement demonstrates Cibus' ability to deliver traits on schedule using its Rapid Trait Development System, with expectati...
Cibus, Inc. has been selected as a key technology partner in a UK Government-funded research project to develop oilseed rape varieties with resistance to Light Leaf Spot disease, which has caused estimated yield losses of £300 million. The LLS-ERASED project will utilize Cibus' proprietary Rapid Trait Development System to create durable, multi-...
Cibus Inc. experienced a pre-market surge of 23.81% following President Trump's trade comments about China, specifically regarding soybeans and cooking oil trade tensions.
Cibus, Inc., a leading agricultural biotechnology company, announced the closing of a $27.5 million public offering to fund further development of its weed management productivity traits in Rice and for working capital and general corporate purposes.
